Cardlytics (NASDAQ:CDLX) Earns "Hold" Rating from Needham & Company LLC

Cardlytics (NASDAQ:CDLX - Get Free Report)'s stock had its "hold" rating reiterated by analysts at Needham & Company LLC in a report released on Friday,Benzinga reports.

A number of other equities analysts have also recently weighed in on the company. Evercore ISI initiated coverage on Cardlytics in a report on Friday, October 11th. They set an "in-line" rating and a $4.00 price target for the company. Craig Hallum upgraded shares of Cardlytics from a "hold" rating to a "strong-buy" rating in a research report on Wednesday, November 6th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, Cardlytics currently has an average rating of "Hold" and a consensus target price of $6.92.

Cardlytics Price Performance

CDLX stock traded up $0.10 during midday trading on Friday, reaching $3.16. The stock had a trading volume of 922,473 shares, compared to its average volume of 750,109. Cardlytics has a 52-week low of $2.76 and a 52-week high of $20.52. The company has a current ratio of 1.18, a quick ratio of 1.18 and a debt-to-equity ratio of 2.40. The company's fifty day simple moving average is $3.69 and its 200 day simple moving average is $4.55. The company has a market cap of $160.59 million, a price-to-earnings ratio of -0.52 and a beta of 1.53.

Cardlytics (NASDAQ:CDLX - Get Free Report) last posted its quarterly earnings results on Wednesday, November 6th. The company reported ($0.15) earnings per share for the quarter, topping the consensus estimate of ($0.33) by $0.18. Cardlytics had a negative net margin of 93.55% and a negative return on equity of 110.67%. The firm had revenue of $67.06 million for the quarter, compared to the consensus estimate of $57.77 million. During the same period last year, the firm posted ($0.26) earnings per share. The company's revenue for the quarter was down 15.1% on a year-over-year basis. As a group, sell-side analysts predict that Cardlytics will post -1.52 earnings per share for the current fiscal year.

Insider Transactions at Cardlytics

In related news, CFO Alexis Desieno sold 25,118 shares of the firm's stock in a transaction that occurred on Friday, November 15th. The shares were sold at an average price of $3.43, for a total value of $86,154.74. Following the sale, the chief financial officer now owns 116,481 shares of the company's stock, valued at $399,529.83. This trade represents a 17.74 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Amit Gupta sold 22,607 shares of the business's stock in a transaction that occurred on Thursday, October 24th. The stock was sold at an average price of $3.85, for a total transaction of $87,036.95. Following the transaction, the chief executive officer now owns 178,519 shares of the company's stock, valued at $687,298.15. This trade represents a 11.24 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 69,007 shares of company stock valued at $251,297. 4.40% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Cardlytics

Several large investors have recently bought and sold shares of the business. Atom Investors LP acquired a new position in shares of Cardlytics in the 3rd quarter valued at $33,000. Tallon Kerry Patrick purchased a new stake in Cardlytics in the fourth quarter valued at $37,000. SG Americas Securities LLC acquired a new position in Cardlytics in the third quarter valued at $45,000. Intech Investment Management LLC purchased a new position in shares of Cardlytics during the third quarter worth about $47,000. Finally, Quadrature Capital Ltd purchased a new position in shares of Cardlytics during the third quarter worth about $63,000. Hedge funds and other institutional investors own 68.10% of the company's stock.

Cardlytics Company Profile

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.